Suppr超能文献

阿尔茨海默病相关认知标志物变化的时间顺序:BLSA 和 WRAP 纵向研究。

Temporal Order of Alzheimer's Disease-Related Cognitive Marker Changes in BLSA and WRAP Longitudinal Studies.

机构信息

Laboratory of Behavioral Neuroscience, Intramural Research Program, National Institute on Aging, Baltimore, MD, USA.

Wisconsin Alzheimer's Institute, University of Wisconsin School of Medicine and Public Health, USA, Madison, WI, USA.

出版信息

J Alzheimers Dis. 2017;59(4):1335-1347. doi: 10.3233/JAD-170448.

Abstract

Investigation of the temporal trajectories of currently used neuropsychological tests is critical to identifying earliest changing measures on the path to dementia due to Alzheimer's disease (AD). We used the Progression Score (PS) method to characterize the temporal trajectories of measures of verbal memory, executive function, attention, processing speed, language, and mental status using data spanning normal cognition, mild cognitive impairment, and AD from 1,661 participants with a total of 7,839 visits (age at last visit 77.6 SD 9.2) in the Baltimore Longitudinal Study of Aging (BLSA) and 1510 participants with a total of 3,473 visits (age at last visit 59.5 SD 7.4) in the Wisconsin Registry for Alzheimer's Prevention (WRAP). This method aligns individuals in time based on the similarity of their longitudinal measurements to reveal temporal trajectories. As a validation of our methodology, we explored the associations between the individualized cognitive progression scores (Cog-PS) computed by our method and clinical diagnosis. Digit span tests were the first to show declines in both data sets, and were detected mainly among cognitively normal individuals. These were followed by tests of verbal memory, which were in turn followed by Trail Making Tests, Boston Naming Test, and Mini-Mental State Examination. Differences in Cog-PS across the clinical diagnosis and APOEɛ4 groups were statistically significant, highlighting the potential use of Cog-PS as individualized indicators of disease progression. Identifying cognitive measures that are changing in preclinical AD can lead to the development of novel cognitive tests that are finely tuned to detecting earliest changes.

摘要

研究当前使用的神经心理学测试的时间轨迹对于识别由于阿尔茨海默病(AD)导致痴呆的最早变化测量指标至关重要。我们使用进展评分(PS)方法,使用来自巴尔的摩纵向衰老研究(BLSA)的 1661 名参与者(最后一次访问时的年龄为 77.6±9.2)和威斯康星州阿尔茨海默病预防登记处(WRAP)的 1510 名参与者(最后一次访问时的年龄为 59.5±7.4)的数据,来描述言语记忆、执行功能、注意力、处理速度、语言和精神状态的测量指标的时间轨迹,这些数据涵盖了正常认知、轻度认知障碍和 AD。在 BLSA 中,该方法基于个体纵向测量的相似性对个体进行时间上的对齐,以揭示时间轨迹。作为我们方法验证的一部分,我们探讨了通过我们的方法计算的个体化认知进展评分(Cog-PS)与临床诊断之间的关联。数字跨度测试在两个数据集中最早显示出下降,并且主要在认知正常的个体中检测到。紧随其后的是言语记忆测试,然后是追踪测试、波士顿命名测试和简易精神状态检查。Cog-PS 在临床诊断和 APOEɛ4 组之间的差异具有统计学意义,突出了 Cog-PS 作为疾病进展个体化指标的潜在用途。识别出在临床前 AD 中发生变化的认知测量指标可以导致开发出针对检测最早变化进行精细调整的新型认知测试。

相似文献

3
Trajectories of cognitive decline in different domains prior to AD onset in persons with mild cognitive impairment.
Arch Gerontol Geriatr. 2024 Jul;122:105375. doi: 10.1016/j.archger.2024.105375. Epub 2024 Feb 20.
4
5
Hypothetical Preclinical Alzheimer Disease Groups and Longitudinal Cognitive Change.
JAMA Neurol. 2016 Jun 1;73(6):698-705. doi: 10.1001/jamaneurol.2016.0194.
6
Early onset Alzheimer's disease is associated with a distinct neuropsychological profile.
J Alzheimers Dis. 2012;30(1):101-8. doi: 10.3233/JAD-2012-111934.
7
Cognitive reserve and Alzheimer's disease biomarkers are independent determinants of cognition.
Brain. 2011 May;134(Pt 5):1479-92. doi: 10.1093/brain/awr049. Epub 2011 Apr 7.
8
Relationships between behavioral syndromes and cognitive domains in Alzheimer disease: the impact of mood and psychosis.
Am J Geriatr Psychiatry. 2012 Nov;20(11):994-1000. doi: 10.1097/JGP.0b013e3182358921.
9
Trajectories of Alzheimer disease-related cognitive measures in a longitudinal sample.
Alzheimers Dement. 2014 Nov;10(6):735-742.e4. doi: 10.1016/j.jalz.2014.04.520. Epub 2014 Jul 14.
10
Longitudinal progression of Alzheimer's-like patterns of atrophy in normal older adults: the SPARE-AD index.
Brain. 2009 Aug;132(Pt 8):2026-35. doi: 10.1093/brain/awp091. Epub 2009 May 4.

引用本文的文献

2
Advancements in deep learning for early diagnosis of Alzheimer's disease using multimodal neuroimaging: challenges and future directions.
Front Neuroinform. 2025 May 2;19:1557177. doi: 10.3389/fninf.2025.1557177. eCollection 2025.
4
Onset ages of cerebrovascular disease and amyloid and effects on cognition in risk-enriched cohorts.
Brain Commun. 2025 Apr 19;7(3):fcaf158. doi: 10.1093/braincomms/fcaf158. eCollection 2025.
6
Integrating amyloid imaging and genetics for early risk stratification of Alzheimer's disease.
Alzheimers Dement. 2024 Nov;20(11):7819-7830. doi: 10.1002/alz.14244. Epub 2024 Sep 17.
9
Harnessing cognitive trajectory clusterings to examine subclinical decline risk factors.
Brain Commun. 2023 Dec 3;5(6):fcad333. doi: 10.1093/braincomms/fcad333. eCollection 2023.
10
Application and validation of an algorithmic classification of early impairment in cognitive performance.
Aging Ment Health. 2023 Nov-Dec;27(11):2187-2192. doi: 10.1080/13607863.2023.2227118. Epub 2023 Jun 24.

本文引用的文献

2
A multivariate nonlinear mixed effects model for longitudinal image analysis: Application to amyloid imaging.
Neuroimage. 2016 Jul 1;134:658-670. doi: 10.1016/j.neuroimage.2016.04.001. Epub 2016 Apr 16.
4
Beta-amyloid and cognitive decline in late middle age: Findings from the Wisconsin Registry for Alzheimer's Prevention study.
Alzheimers Dement. 2016 Jul;12(7):805-14. doi: 10.1016/j.jalz.2015.12.009. Epub 2016 Jan 21.
5
Sex differences in cognitive trajectories in clinically normal older adults.
Psychol Aging. 2016 Mar;31(2):166-75. doi: 10.1037/pag0000070. Epub 2016 Jan 21.
6
Multi-stage Biomarker Models for Progression Estimation in Alzheimer's Disease.
Inf Process Med Imaging. 2015;24:387-98. doi: 10.1007/978-3-319-19992-4_30.
7
Cognitive and Brain Profiles Associated with Current Neuroimaging Biomarkers of Preclinical Alzheimer's Disease.
J Neurosci. 2015 Jul 22;35(29):10402-11. doi: 10.1523/JNEUROSCI.0150-15.2015.
8
Memory, executive, and multidomain subtle cognitive impairment: clinical and biomarker findings.
Neurology. 2015 Jul 14;85(2):144-53. doi: 10.1212/WNL.0000000000001738. Epub 2015 Jun 17.
10
Amyloid-β, anxiety, and cognitive decline in preclinical Alzheimer disease: a multicenter, prospective cohort study.
JAMA Psychiatry. 2015 Mar;72(3):284-91. doi: 10.1001/jamapsychiatry.2014.2476.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验